We will achieve our long term business objective, which is to ensure sustained profitable growth and Total Shareholder Return (TSR), by delivering upon our VISION of being a premier international pharmaceutical company focused on providing valuable orphan drugs and niche specialty products and services to patients with high unmet medical needs.
Swedish Orphan Biovitrum makes use of the company’s combined resources for external and internal communication to investors, media, customers and to the organization in a decentralized way. The competence and knowledge possessed within the different parts of the company are used to identify communications needs and opportunities and to produce content. Final results are signed off and made public through the coordinating responsibility of Corporate Communications. Framework, content support, graphical manual, policies, overall corporate content and checking all external communication for quality from these perspectives are thus among the responsibilities of Corporate Communications. Our goal is that all communication should be service minded, clear, simple, open, fast, consistent, relevant and interesting.
Swedish Orphan Biovitrum aims at fulfilling the highest standards of communications. We strive to continuously project an accurate and current image of Swedish Orphan Biovitrum to keep our staff and stakeholders well-informed and up-to-date. Our ambition is to be objective and transparent, but the degree of transparency is tailored to meet the need for business confidentiality and the formal requirements on publicly listed companies. This applies particularly to information concerning the company’s financial performance, its financial position or other information that could influence the share price.